Beruflich Dokumente
Kultur Dokumente
Malaria
Animal Sciences
Stephanie A. Lanoue
Full Text:
Page 93
Malaria
Malaria is one of the oldest known infections. It is also the world's most deadly tropical parasitic disease. It kills
more people than any other communicable disease except tuberculosis. The disease was first described in ancient
Sanskrit and Chinese documents. Hippocrates also described the disease in his writings. It is believed that the army
Page 94 |
of Alexander the Great was wiped out by the disease during its march across India.
Malaria is thought to have been introduced into the United States by European colonists and African slaves in the
sixteenth and seventeenth centuries. It is now endemic in ninety-two countries worldwide. With approximately 41
percent of the world's population at risk, the disease poses a serious health threat globally. As many as two million
people die annually; half of the deaths occur in children under five years of age. According to the World Health
Organization, this amounts to one child dying every thirty seconds.
Malaria is characterized by both acute and relapsing infection in humans. Hallmark symptoms include periodic
episodes of chills and fever, spleen enlargement, and anemia. The disease is caused by microscopic onecelled
organisms called sporozoa, which belong to the genus Plasmodium. These parasites are transmitted to humans by
several species of anopheles mosquitoes. Malaria is also found in apes, monkeys, birds, bats, reptiles, and rodents.
While humans can be infected only by Anopheles mosquitoes, birds and other animals are known to have become
ill after being bitten by mosquitoes from the genus Culex.
Four species of Plasmodium are known to cause human malaria: P. falciparum, P. vivax, P. malariae, and P. ovale.
Diagnosis can be determined by a blood smear. The most common type, P. falciparum, requires relatively high
environmental temperatures for development and is usually found in tropical areas such as western Africa. P. vivax
malaria accounts for 43 percent of all cases and is widespread globally. It is known to occur even in cold-winter
areas of Korea, Manchuria, and south Russia. The less common P. malariae malaria occurs in about 7 percent of all
cases and is confined to the Mediterranean, while P. ovale malaria is rather rare and isolated within a small area of
Mosquito Transmission
Though malaria can occur in temperate regions, it is most common in the tropics and subtropics, where climatic
conditions favor mosquito development. Mosquitoes lay their eggs in water where larvae mature and hatch into
flying adults. Newly hatched female mosquitoes are especially bloodthirsty and require a blood meal to produce
fertile eggs. When these mosquitoes bite a human who is already infected, they ingest the malarial parasite and the
disease transmission cycle begins.
The life cycle of the Plasmodium starts in the stomach of the female mosquito. The organism's double life cycle has
two phasesa sexual reproductive cycle and an asexual reproductive cycle. While the parasite is in its asexual,
free-swimming stage, it is known as a sporozoite. When an infected mosquito bites, the sporozoite is injected along
with saliva into the human bloodstream.
Page 95 |
Page 96 |
Once inside the bloodstream, the sporozoite enters a red blood cell. Inside the red blood cell, it changes shape and
divides into smaller forms called merozoites. The red blood cell containing these merozoites ruptures, releasing
them into the blood. The merozoites infect other red blood cells, and the life cycle is repeated. The rupturing of red
blood cells causes the symptoms of fever and chills.
A mosquito biting an infected host at this stage can ingest merozoites. If this happens, the merozoites enter the
mosquito's stomach and become male and female gametocytes. This kicks off a sexual reproductive life cycle
where the separate male and female gametocytes unite together to form a single-celled zygote. This zygote grows to
become an oocyst or large egglike sac, which eventually divides, releasing a multitude of asexual, freeswimming
sporozoites.
These sporozoites move to the mosquito's head and salivary glands from which they can be injected into a human
during the mosquito's next bite. This asexual cycle is repeated. During the asexual life cycle, the parasites grow and
divide synchronously. The resulting merozoites produce the regularly occurring fever and chill attacks that are
typical of malaria.
predicted to increase by 5 percent a year for the first twenty years of the twenty-first century.
Resurgence and increased risk of the disease appears to be linked to several factors. Changes in land use, such as
mining, logging, and agricultural projects, particularly in the Amazon and Southeast Asia frontier area, are
providing new mosquito breeding sites. Other reasons for the disease's spread include global climatic changes,
disintegration of health services, armed conflicts, and mass movements of refugees into areas of high malaria
transmission.
Reemergence of malaria through mobility occurred in Brazil, for example. Malaria had been practically eradicated
from most areas of the Amazon region until massive population movements began to colonize new territories. New
highways were built, linking the Amazon to the rest of the country and attracting laborers to work on road
construction. In 1970, prior to new road construction in these new areas, there were approximately 50,000 cases of
malaria reported; by 1990, reports had increased to more than 500,000, representing 10 percent of the world's
reported cases outside Africa.
As a result of the explosion of international travel, imported cases of malaria are now showing up more in
developed countries such as the United States Malaria is also reemerging in areas where it was previously under
control or eradicated, such as in Korea. According to the WHO, global warming and other climatic events such as
El Nio also play a role in increasing the disease. Malaria has now spread to highland areas of Africa, where El
Nio effects such as increased rainfall have influenced mosquito breeding sites and hence the transmission of the
disease. The emergence of multidrug-resistant strains of parasites is also exacerbating the situation.
Disease Prevention
Prevention of malaria encompasses a variety of measures. Some may protect against infectionthese are directed
against mosquitoeswhereas others focus on stopping the development of the disease in human beings. Although
only a limited number of drugs are available, if these are used properly and targeted to those at greatest risk, malaria
can be reduced.
Since the early 1990s, considerable progress has been made in the search for a malaria vaccine. More than a dozen
candidate vaccines are currently in development; some of them are in clinical trials. An effective vaccine could be
available within the first twenty years of the twenty-first century. In the meantime, there are a number of
prescription drugs available on the market in developed countries that can help prevent malaria, especially in
individuals traveling to high incidence areas. Some of the best-known preventatives include Mefloquine, Malarone,
and Primaquine.
Medical researchers continue to discover new drug therapies. Most recently, Chinese scientists discovered a drug
called artemether that is derived from the Chinese herb qinghaosu. The new drug appears to be as effective as
quinine although much slower acting. It may even kill resistant strains of malaria.
SEE ALSO
Stephanie A. Lanoue
Page 98 |
Bibliography
Noble, Elmer R., Glenn A. Noble, Gerhard A. Schad, and Austin J. MacInnes. Parasitology. London: Lea &
Febiger, 1989.
Turkington, Carol, and Bonnie Ashby. Encyclopedia of Infectious Disease. New York: Facts on File, Inc., 1998.
Source Citation (MLA 7th Edition)
Lanoue, Stephanie A. "Malaria." Animal Sciences. Ed. Allan B. Cobb. Vol. 3. New York: Macmillan Reference
USA, 2002. 93-98. Gale Virtual Reference Library. Web. 8 May 2015.
URL
http://go.galegroup.com/ps/i.do?
id=GALE|CX3400500219&v=2.1&u=j057911&it=r&p=GVRL&sw=w&asid=2abd72cd28778c47870cb419ff6cba67
Gale Document Number: GALE|CX3400500219